SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-09-001385
Filing Date
2009-02-19
Accepted
2009-02-19 07:18:25
Documents
2
Period of Report
2009-02-19
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ANTIGENICS INC. 8-K a5899643.htm 8-K 18572
2 EXHIBIT 99.1 a5899643_ex991.htm EX-99.1 47463
  Complete submission text file 0001157523-09-001385.txt   67564
Mailing Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010
Business Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010 212-994-8200
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 09620080
SIC: 2836 Biological Products, (No Diagnostic Substances)